Novartis to launch AI innovation lab with Microsoft as its strategic AI and data-science partner to transform the discovery- development & commercialization of medicines by leveraging AI & data intelligence
The strategic alliance will collaborate Novartis’ life sciences expertise with the power of Azure and Microsoft AI with the two main objectives i.e- AI Empowerment & AI Exploration
The multi-year research and development agreement will involve joint research activities at Novartis Campus (Switzerland)- at Novartis Global Service Center in Dublin- and at Microsoft Research Lab (UK) initiating with personalized therapies for macular degeneration- cell & gene therapy and drug design
Click here to read full press release/ article | Ref: Microsoft | Image: Windows Central
